在冠状动脉疾病的老年人中了解药物自我管理:一种定性研究
Mengqi Xu1, Suzanne Hoi Shan Lo1, Lingyan Zhu2
1The Nethersole School of Nursing, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, People's Republic of China.
Patient preference and adherence
|October 6, 2025
概括
患有冠状动脉疾病的老年人面临着在家里管理药物的挑战,在新疗法和坚持方面扎. 改善支持,以患者为中心的沟通和护理人员的参与对于更好的药物自我管理至关重要.
科学领域:
- 老年学是一门学科.
- 心脏病学 心脏病学
- 健康管理健康管理
背景情况:
- 在冠状动脉疾病 (CAD) 的老年人中,药物自我管理是不理想的.
- 处方药和实际药物使用之间的差异是常见的.
- 需要加强家庭药物管理的支持系统.
研究的目的:
- 探索和理解在家中药物自我管理的复杂性.
- 为了确定老年人与CAD在管理他们的药物方面所面临的挑战.
- 收集有关改善药物坚持和自我有效性的见解.
主要方法:
- 在2024年6月至8月期间进行了一项描述性定性研究.
- 对28名患有CAD的老年人和6名医疗保健专业人员进行了采访.
- 对面对面或虚拟半结构面试的数据进行了专题分析.
主要成果:
- 两个主要主题出现了:"在开始新疗法时应对未知因素"和"探索支持药物坚持的策略".
- 老年人遇到困难寻找令人满意的信息,并将药物纳入日常生活.
- 挑战包括对医疗保健专业人员的依赖,不充分的自我信息搜索,使用辅助工具和护理人员的帮助.
结论:
- 患有CAD的老年人需要更好的支持,以适应新的药物治疗方案并改善遵守.
- 未来的干预措施应侧重于以患者为中心的沟通,同行教育,可靠的信息资源和护理人员参与.
- 提高药物自我有效性是关键,需要改善获得准确信息和管理辅助工具的机会.
相关概念视频
Angina V: Nursing Management
287
Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...
287
Coronary Artery Disease V: Interprofessional Care
215
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
215
Atherosclerosis III: Management
319
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
319
Coronary Artery Disease IV: Preventive Measures
589
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
589
Drug Dosing: Geriatric Patients
225
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
225
Angina IV: Management
236
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
236

